These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12160583)

  • 41. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.
    D'Amico AV; Whittington R; Malkowicz B; Schnall M; Schultz D; Cote K; Tomaszewski JE; Wein A
    J Urol; 2000 Sep; 164(3 Pt 1):759-63. PubMed ID: 10953141
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparisons of Oncological and Functional Outcomes Between Primary Whole-Gland Cryoablation and High-Intensity Focused Ultrasound for Localized Prostate Cancer.
    Liu YY; Chiang PH
    Ann Surg Oncol; 2016 Jan; 23(1):328-34. PubMed ID: 26088651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
    de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
    BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
    Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
    J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
    Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
    Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histological presence of viable prostatic glands on routine biopsy following cryosurgical ablation of the prostate.
    Shuman BA; Cohen JK; Miller RJ; Rooker GM; Olson PR
    J Urol; 1997 Feb; 157(2):552-5. PubMed ID: 8996354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryoablation of localized prostate cancer. Experience in 48 cases, PSA and biopsy results.
    Derakhshani P; Neubauer S; Braun M; Zumbé J; Heidenreich A; Engelmann U
    Eur Urol; 1998 Sep; 34(3):181-7. PubMed ID: 9732189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
    Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
    J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
    Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
    Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology.
    Polascik TJ; Nosnik I; Mayes JM; Mouraviev V
    Urology; 2007 Jul; 70(1):117-21. PubMed ID: 17656220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer.
    Galalae RM; Kovács G; Schultze J; Loch T; Rzehak P; Wilhelm R; Bertermann H; Buschbeck B; Kohr P; Kimmig B
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):81-90. PubMed ID: 11777625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostate cryoablation: prospective analysis comparing high- and low-risk prostate cancer outcomes.
    El Hayek OR; Alfer W; Reggio E; Pompeo AC; Arap S; Lucon AM; Srougi M
    Urol Int; 2008; 81(2):186-90. PubMed ID: 18758217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ferromagnetic thermal ablation of locally recurrent prostate cancer: prostate specific antigen results and immediate/intermediate morbidities.
    Master VA; Shinohara K; Carroll PR
    J Urol; 2004 Dec; 172(6 Pt 1):2197-202. PubMed ID: 15538231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery.
    Gould RS
    J Urol; 1999 Nov; 162(5):1653-7. PubMed ID: 10524891
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
    Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
    BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased serum total creatine kinase and creatine kinase isoenzyme MB after cryosurgical ablation of the prostate.
    Long JP; Fallick ML; Rand W
    J Urol; 1997 May; 157(5):1723-6. PubMed ID: 9112513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.